Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
The Graphic Truth: Competing and cooperating on a COVID-19 vaccine
The global race is on to develop a vaccine against COVID-19. While it usually takes many years to develop and widely distribute vaccines, scientists around the world are now trying to get one ready within the next year — an unprecedented time frame.
The race has generated fierce competition among countries, as everyone wants to develop a vaccine on their home turf first, not only for prestige, but also to get their citizens at the front of the line for the shots when they are available. Still, while the scientific world is now rife with geopolitical rivalries over the COVID-19 vaccine, there's also a lot of international collaboration going on behind the scenes. Here's a look at the vaccines currently in Phase II of the clinical trial process, meaning they are being tested on hundreds of people of various age groups to determine their effectiveness and safety. If they pass this stage they move to wider testing in Phase III, the final step before approval.